share_log

歐康維視生物-B:須予披露交易 收購在中國的埃美丁及貝特舒權利

Ocumension Therapeutics-B: DISCLOSEABLE TRANSACTION ACQUISITION OF RIGHTS RELATING TO EMADINE AND BETOPTIC S IN CHINA

Aug 23, 2021 18:41
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more